Healthcare Equipment and Supplies
Company Overview of FzioMed, Inc.
FzioMed, Inc., a medical device company, develops, manufactures, and commercializes biomaterial technology for use in surgery and other medical applications. It offers adhesion barrier gels for spine surgery as an adjunct to posterior lumbar laminectomy, laminotomy, or discectomy procedures for reducing pain, radiculopathy, and lower extremity weakness; and the incidence, extent, and severity of postoperative adhesions. The company also provides adhesion barrier gels for tendon and peripheral nerve surgery to coat surgically traumatized tissues during tendon and/or peripheral nerve surgeries, such as in foot, knee, shoulder, and hand surgery. In addition, FzioMed, Inc. offers absorbable adhe...
231 Bonetti Drive
San Luis Obispo, CA 93401
Founded in 1996
Key Executives for FzioMed, Inc.
Chief Executive Officer and President
Founder and Executive Chairman
Vice President of Clinical Affairs
Vice President of Research and Development
Compensation as of Fiscal Year 2014.
FzioMed, Inc. Key Developments
FzioMed Receives Approval for Dynavisc(R) in Australia
May 6 13
FzioMed announced the inclusion of Dynavisc on the Australian Register of Therapeutic Goods (ARTG). Dynavisc is an absorbable, clear, viscoelastic gel that is applied to tendons and peripheral nerves to reduce fibrosis and the formation of adhesions following surgery. Dynavisc received a CE mark in January 2012 and is sold in the EU through independent distributors. Dynavisc, is a sister product to Oxiplex(R) and Medishield(TM) (distributed by Medtronic), which have been marketed for more than ten years in 70 countries to reduce the incidence of adhesions and for the reduction of pain after spine surgery. Oxiplex is not yet approved in the United States despite having demonstrated safety and effectiveness in clinical studies involving more than 500 patients. A Citizen Petition under 21 CFR 10.33 is still under review by FDA.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries